Carcinoma hepatocelular y colangiocarcinoma intrahepático en pacientes con cirrosis hepática

Barra lateral del artículo

PDF
Publicado: 10-12-2011
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v31i4.957

Contenido principal del artículo

Oscar Sabino Chirife Chaparro
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España
Ramón Vilana Puig
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España
Luis Bianchi Cardona
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España
Concepción Bru Saumell
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España

Resumen

.

Downloads

Download data is not yet available.

Detalles del artículo

Número

Vol. 31 Núm. 4 (2011): Revista del Hospital Italiano de Buenos Aires

Sección

Ateneo radiológico
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Cómo citar

1.
Chirife Chaparro OS, Vilana Puig R, Bianchi Cardona L, Bru Saumell C. Carcinoma hepatocelular y colangiocarcinoma intrahepático en pacientes con cirrosis hepática. Rev Hosp Ital B.Aires [Internet]. 2011 Dec. 10 [cited 2026 Apr. 26];31(4):146-9. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/957

Referencias

Yuen MF, Tanaka Y, Fong DY, et al. In-dependent risk factors and predictive score for the development of hepatocellular car-cinoma in chronic hepatitis B. J Hepatol. 2009;50(1):80-8. DOI: https://doi.org/10.1016/j.jhep.2008.07.023

Hammill CW, Wong LL. Intrahepatic cholan-giocarcinoma: a malignancy of increasing impor-tance. J Am Coll Surg. 2008;207(4):594-603. DOI: https://doi.org/10.1016/j.jamcollsurg.2008.04.031

Forner A, Reig ME, de Lope CR, et al. Cur-rent strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61-74. DOI: https://doi.org/10.1055/s-0030-1247133

Yachimski P, Pratt DS. Cholangiocarcino-ma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol. 2008;42(2):178-90. DOI: https://doi.org/10.1097/MCG.0b013e31806daf89

Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepa-tology. 2011;53(3):1020-2. DOI: https://doi.org/10.1002/hep.24199

Bruix J, Sherman M, Llovet JM, et al. Clini-cal management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol. 2001;35(3):421-30. DOI: https://doi.org/10.1016/S0168-8278(01)00130-1

Bruix J, Sherman M; Practice Guide-lines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-36. DOI: https://doi.org/10.1002/hep.20933

Forner A, Vilana R, Ayuso C, et al. Diag-nosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the non-invasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47(1):97-104. Errata en: Hepatology. 2008;47(2):769. DOI: https://doi.org/10.1002/hep.21966

Vilana R, Forner A, Bianchi L, et al. In-trahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pat-tern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 2010;51(6):2020-9. DOI: https://doi.org/10.1002/hep.23600

Chen LD, Xu HX, Xie XY, et al. Enhance-ment patterns of intrahepatic cholangiocarci-noma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Ra-diol. 2008;81(971):881-9.

Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recom-mendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008;29(1):28-44. DOI: https://doi.org/10.1055/s-2007-963785

Chen LD, Xu HX, Xie XY, et al. Enhance-ment patterns of intrahepatic cholangiocarci-noma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Ra-diol. 2008;81(971):881-9. DOI: https://doi.org/10.1259/bjr/22318475

Rimola J, Forner A, Reig M, et al. Chol-angiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by mag-netic resonance imaging avoids misdiagno-sis of hepatocellular carcinoma. Hepatology. 2009;50(3):791-8. DOI: https://doi.org/10.1002/hep.23071

Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roent-genol. 2001;176(6):1499-507. DOI: https://doi.org/10.2214/ajr.176.6.1761499